
Omar T Atiq MD MACP
Head & Neck Cancer, Melanoma, Thoracic Cancer
Distinguished Professor of Medicine and Otolaryngology-Head and Neck Surgery, Omar T. Atiq, MD, MACP Distinguished Chair in Physician Leadership, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences; Former Director, Cancer Service Line, UAMS Heath
UAMS Medical Center449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Seventh FloorLittle Rock, AR 72205
Phone+1 501-686-8530
Dr. Atiq is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
Loyola University Medical CenterChief Residency, Internal Medicine, 1988 - 1989
Loyola University Medical CenterResidency, Internal Medicine, 1985 - 1988
Khyber Medical CollegeClass of 1983
Pakistan Air Force CollegeF.Sc., 1976 - 1977
Certifications & Licensure
AR State Medical License 1991 - 2028
NY State Medical License 1988 - 1992
PA State Medical License 1991 - 1992
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- President American College of Physicians
- President Elect American College of Physicians
- Lifetime Achievement Award Association of Physicians of Pakistani Descent of North America, 2022
Clinical Trials
- A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients Start of enrollment: 2019 Nov 13
Publications & Presentations
PubMed
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurre...Emily Bivens, Omar Atiq, Teresa Evans, Milan Bimali, Ginger Brown
Medrxiv. 2026-01-12 - 1 citationsStem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care.Shi-Ming Tu, Anup K Trikannad, Sruthi Vellanki, Munawwar Hussain, Nazish Malik
Cancers. 2024-03-14 - Erythrocyte PIG-A mutant frequencies in cancer patients receiving cisplatin.Vasily N Dobrovolsky, Omar T Atiq, Robert H Heflich, Mackean Maisha, Page B McKinzie
Cancer Medicine. 2024-02-01
Journal Articles
- A Phase II Trial of Postoperative Intraperitoneal Cisplatin and Fluorouracil and Systemic Fluorouracil Chemotherapy in Patients with Resected Gastric CancerAtiq O, Kelsen DP, Shiu MH, et al, J Clin Oncol, 1/1/1993
- Treatment of Unresectable Primary Liver Cancer with Intrahepatic Fluorodeoxyuridine and Mitomycin C via an Implantable PumpAtiq O, Kemeny N, Niedzwiecki D, Botet J, Cancer, 1/1/1992
- Cutaneous T-Cell Lymphoma Presenting with Diffuse Lymphomatous Infiltration of the Peripheral Nerves: Response to Combination ChemotherapyAtiq OT, DeAngelis LM, Rosenblum M, Portlock CS, Am J Clin Oncol (CCT), 1/1/1992
Books/Book Chapters
Abstracts/Posters
- Bortezomib + irinotecan in relapsed/refractory colorectal cancer (CRC): Interim analysis results from phase (ph) 2b study.T. Dragovich, H. J. Lenz, C. M. S. Rocha Lima, P. Kozuch, H. Hochster, B. O'Neil, O. Atiq, J. M. Pipas, O. Kashala, D. P. Schenkein, Proc Am Soc Clin Oncol, 1/1/2004
- Treatment of Hormone-Refractory Prostate Adenocarcinoma with Estramustine and Vinblastine Chemotherapy.Atiq O, Lewis, B, Proc Am Soc Clin Oncol, 1/1/1994
- Efficacy of Mitomycin, Vinblastine and Cisplatin chemotherapy in Unresectable Non-Small Cell Lung Cancer.Atiq O, Rollins J, Proc Am Soc Clin Oncol, 1/1/1994
Press Mentions
10 Memoirs That Offer Inspiring Accounts of Life in MedicineFebruary 12th, 2026
AMP 2025 Champions of Health CareAugust 15th, 2025
What Doctors Wish Patients Knew About Lung Cancer ScreeningMay 23rd, 2025
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: